Abstract
The first examples of selective ortho-directed C-H activation with unprotected 2-aryltetrazoles are described. A new base-assisted protocol for iridium (I) hydrogen isotope exchange catalysis allows access to ortho-deuterated and tritiated tetrazoles, including the tetrazole-containing pharmaceutical, Valsartan. Preliminary mechanistic studies are also presented.
| Original language | English |
|---|---|
| Pages (from-to) | 6669-6672 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 52 |
| Issue number | 40 |
| Early online date | 20 Apr 2016 |
| DOIs | |
| Publication status | E-pub ahead of print - 20 Apr 2016 |
Keywords
- iridium (I) hydrogen isotope exchange catalysis
- ortho-directed C-H activation
- 2-aryltetrazoles